Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$9.97

Avg closing price
Price range

2 Paul Tudor Jones II SAB Biotherapeutics Trades

Paul Tudor Jones II started to build up the position in SAB Biotherapeutics in Q3 2021. Since then they sold 6 Thousand shares. The investor sold all their shares in Q4 2021 and doesn't own any shares in SAB Biotherapeutics anymore.

Avg closing price
Price range
Sold -6 Thousand shares Q4 2021
Avg closing price $71.30
Price range $8.44 - $112.40
New holding (+6 Thousand shares) Q3 2021
Avg closing price $9.97
Price range $9.89 - $10.08

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!